Comparison of progenitor cell content in sequential peripheral blood progenitor collections after mobilization with chemotherapy and granulocyte macrophage colony-stimulating factor

Acta Haematologica

Volumn 99, Issue 2, 1998, Pages 69-75

  Chang, Eric ^a   Parker, John ^a   Groshen, Susan ^a   Watkins, Kristy ^a   Douer, Dan ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

BFU E; CD34+ cells; CFU GM; Peripheral blood progenitor collections

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BURST FORMING UNIT E; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; CELL COUNT; CYCLOPHOSPHAMIDE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031933005     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040813     Document Type: Article

References (47)

1. Armitage JO: Bone marrow transplantation. N Engl J Med 1994;330:827-838.
2. Bitran JD, Martinec J, Okuno T, White L, Hanauer S, Klein L, Samuels B: Autologous bone-marrow transplantation using peripheral-blood hematopoietic progenitor cells - the total number of CD34+ cells/kg predicts for hematologic engraftment (abstract 288). Blood 1993; 82.
3. Raptis G, Vahdat L, Fennelly D, Reich L, Hamilton N, Yao TJ, Bengala C, Schneider J, Shapiro F: Peripheral-blood progenitor supported high-dose chemotherapy - Determination of a threshold number of CD34+ cells for reliable engraftment (abstract 289a). Blood 1993;82.
4. Gianni AM, Bregni M, Siena S, Villa S, Sciorelli GA, Ravagnani F, Pellegris G, Bonadonna G: Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy? Hematol Oncol 1989;7:139-148.
5. Weaver CH, Hazleton B, Brich R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-3969.
6. Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autographing in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992;9: 459-465.
7. Serke S, Kirsch A, Huhn D: Mobilization of circulating haemopoietic cells (blood stem cells) by GM-CSF in patients with malignancies. Infection 1992;20(suppl2):S100-S102.
8. Teshima T, Harada M, Takamatsu Y, Makino K, Taniguchi S, Inaba S, Kondo S, Tanaka T, Akashi K, Minamishima I: Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant 1992;10:215-220.
9. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992;79:1193-1200.
10. Ho AD, Haas R, Korbling M, Dietz M, Hunstein W: Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplant 1991;7(suppl 1):13-17.
11. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79:3036-3044.
12. Patrone F, Ballestrero A, Balleari E, Bogliolo F, Brema F, Ferrando F, Ghio R, Timitilli S: High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells. Haematologica 1992;77:457-462.
13. Elias AD, Mazanet R, Wheeler C, Anderson K, Ayash L, Schwartz G, Tepler I, Pap S, Pelaez J, Hunt M: Gm-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols. Breast Cancer Res Treat 1991;20(suppl):S25-S29.
14. Tarella C, Ferrero D, Bregni M, Siena S, Gallo E, Pileri A, Gianni AM: Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991;27:22-27.
15. Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J: Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993;81:1709-1719.
16. Rosenfeld CS, Nemunaitis J: The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology. Semin Hematol 1992;29(suppl3):19-26.
17. Juttner CA, To LB, Haylock DN, Dyson PG: Peripheral blood stem cell selection, collection and auto-transplantation. Prog Clin Biol Res 1990;333:447-459.
18. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp DL, Dale BM, Dart GW, Roberts MM, Sage RE: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990;18:442-447.
19. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Landsdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
20. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony stimulating factor to havest circulating hematopoietic stem cells for autotransplantation. Lancet 1989;2:580-585.
21. Tarella C, Ferrero D, Bregni M, Siena S, Gallo E, Pileri A, Gianni AM: Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991;27:22-27.
22. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
23. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Gregg A, Pillow A, Bolton A: Factors affecting blood stem cell collections following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992;9:11-17.
24. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: Enhancement by intravenous human granulocyte macrophage colony stimulating factor. Blood 1989;74:1905-1914.
25. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD: Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988;i:1194-1198.
26. Bishop MR, Anderson JR, Jackson JD, Bierman PJ, Reed EC, Vose JM, Armitage JO, Warkentin PI, Kessinger A: High dose therapy and peripheral blood progenitor transplantation: Effects of recombinant human GM-CSF. Blood 1994;83:610-616.
27. Rabinowitz AP, Watkins K, Groshen S, Chen SC, Rosen P, Mazumder A: Peripheral blood stem cells harvested during marrow recovery from disease-specific chemotherapy shorten duration of neutropenia in patients undergoing autologous bone marrow transplantation. Leuk Lymphoma 1993;9:485-493.
28. Passos-Coelho JL, Braine H, Davis JM, Schepers KG, Clarke B, Ohly K, Huelskamp A, Noga SJ, Davidson NE: Primed peripheral blood stem cells collected in a single large volume leukapheresis accelerate hematopoietic recovery after high-dose chemotherapy (abstract 323a). Blood 1993;82.
29. Janssen WE, Farmelo MJ, Lee C, Smilee R, Kronish L, Elfenbein GJ: The CD34+ cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 1992; 20:528-530.
30. Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H: CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991;19:1079-1083.
31. Teixeira G, Lenormand B, Jean P, Fardoun D, Sumereau-Dassin E: Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. Am J Hematol 1992;39:172-175.
32. Schwartzberg L, Birch R, Blanco R, Wittlin F, Muscato J, Tauer K, Hazelton B, West W: Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993;11:369-374.
33. Ikematsu W, Teshima T, Kondo S, Makino S, Okamwa S, Inaba S, Harada M, Niho Y: Circulating CD34+ hematopoietic progenitors in the harvesting peripheral blood stem cells; enhancement by recombinant human granulocyte colony-stimulating factor. Biotherapy 1992;5: 131-136.
34. Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Bonadonna G, Gianni M: Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. Haematologica 1991;76:330-333.
35. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987;70:1316-1324.
36. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-165.
37. Leary AG, Strauss LC, Civin CI, Ogawa M: Disparate differentiation in hematopoietic colonies derived from human paired progenitors. Blood 1985;66:327-332.
38. Leary AG, Ogawa M, Strauss LC, Civin CI: Single cell origin of multilineage colonies in culture: Evidence that differentiation of multipotent progenitors are stochastic processes. J Clin Invest 1984;74:2193-2197.
39. Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E: Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with MY10 and major histocompatibility class II monoclonal antibodies. J Immunol 1987;139: 1823-1829.
40. Briddell RA, Brandt JE, Straneva JE, Srour EF, Hoffman R: Characterization of the human burst-forming unit-megakaryocyte. Blood 1989;74:145-151.
41. Ryan D, Kossover S, Mitchell S, Frantz C, Hennessy L, Cohen H: Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 1986;68:417-425.
42. Pettengell R, Testa NG, Swindell R, Crowther D, Dexter TM: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993;82:2239-2248.
43. Boiron JM, Marit G, Faberes C, Cony-Makhoul P, Fournes C, Ferrer AM, Cristol G, Sarrat A, Girault D, Reiffers J: Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 1993;12:49-55.
44. Gazitt Y, Tian E, Barlogie B, Reading CL, Vesole DH, Jagannath S, Schnell J, Hoffman ER, Tricot G: Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony stimulating factor. Blood 1996; 87:805-811.
45. Reiffers J, Faberes C, Boiron M, Marit G, Foures C, Ferrer AM, Cony-Makhoul P, Puntous M, Gilles E: Peripheral-blood progenitor-cell (PBPC) transplantation in 118 patients with hematological malignancies - analysis of factors affecting the rate of engraftment (abstract 116a). Blood 1993;82.
46. Carella AM, Pollicardo N, Raffo MR, Podesta M, Carlier P, Valbonesi M, Lercari G, Vitale V, Gallamini A: Intensive conventional chemotherapy can lead to a precocious overshoot of cytogenetically normal blood stem cells (BSC) in chronic myeloid leukemia and acute lymphoblastic leukemia. Leukemia 1992;6(suppl 4):120-123.
47. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-640.